Brokers Offer Predictions for Gilead Sciences Q4 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Research analysts at Leerink Partnrs issued their Q4 2025 earnings per share (EPS) estimates for Gilead Sciences in a report released on Wednesday, February 12th. Leerink Partnrs analyst D. Graybosch forecasts that the biopharmaceutical company will post earnings per share of $1.72 for the quarter. Leerink Partnrs […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Research analysts at Leerink Partnrs issued their Q4 2025 earnings per share (EPS) estimates for Gilead Sciences in a report released on Wednesday, February 12th. Leerink Partnrs analyst D. Graybosch forecasts that the biopharmaceutical company will post earnings per share of $1.72 for the quarter. Leerink Partnrs […]
